Periplocin extracted from cortex periplocae induces apoptosis of SW480 cells through inhibiting the Wnt/β-catenin signaling pathway

Chinese Journal of Cancer

Volumn 28, Issue 5, 2009, Pages

  Du, Yan Yan ^a   Liu, Xin ^a   Shan, Bao En ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Cell apoptosis; Cell cycle; Colorectal neoplasm; Periplocin extracted from cortex periplocae; SW480 cells; Wnt catenin signaling pathway

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANTINEOPLASTIC AGENT; BETA CATENIN; CYCLIN D1; MESSENGER RNA; MYC PROTEIN; PERIPLOCIN; SURVIVIN; UNCLASSIFIED DRUG; WNT PROTEIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; COLON CARCINOMA; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG BINDING SITE; DRUG DNA BINDING; FLOW CYTOMETRY; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; GENE TARGETING; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 77954365693     PISSN: 1000467X     EISSN: 1944446X     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Terstappen GC, Gaviraghi G, Caricasole A. The Wnt signaling pathway as a target for the treatment of neurodegenerative disorders [J]. IDrugs, 2006, 9(1): 35-38.
2. Dihlmann S, von Knebel Doeberitz M. Wnt/beta-catenin-pathway as a molecular target for future anti-cancer therapeutics [J]. Int J Cancer, 2005, 113(4): 515-524.
3. Chinese Pharmacopoeia Commission. Chinese Pharmacopoeia [M]. Beijing, Chemical Industry Press, 2006: 181. [in Chinese]
4. Zhang J, Shan BE, Liu GL, et al. Anti-tumor activity of extract from periploca sepium bge [J]. Ai Bian, Ji Bian, Tu Bian, 2006, 2(12): 108-111. [in Chinese]
5. Zhang YJ, Lu G, Shan BE, et al. The Relationship between suppressive effects of cortex periplocae on BT-549 cells and expression of p16 and p27 [J]. Ai Bian, Ji Bian, Tu Bian, 2008, 20(3): 216-219. [in Chinese]
6. Park CH, Chang JY, Hahm ER, et al. Quercerin, a potent inhibitor against beta-catenin/TCF signaling in SW480 colon cancer cell [J]. Biochem Biophys Res Commun, 2005, 328(1): 227-234.
7. Haydon RC, Deyrup A, Ishikawa A, et al. Cytoplasmic and/ or nuclear accumulation of the beta-catenin protein is a frequent event in human osteosarcoma [J]. Int J Cancer, 2002, 102(4): 338-342.
8. Mi K, Dolan PJ, Johnson GV. The low density lipoprotein receptor-related protein 6 interacts with glycogen synthase kinase 3 and attenuates activity [J]. J Biol Chem, 2006, 281 (8): 4787-4794.
9. DasGupta R, Kaykas A, Moon RT, et al. Functional genomic analysis of the Wnt-wingless signaling pathway [J]. Science, 2005, 308(5723): 826-833.
10. Ma H, Nguyen C, Lee KS, et al. Differential roles for the coactivators CBP and p300 on TCF/β-catenin-mediated survivin gene expression [J]. Oncogene, 2005, 24(22): 3619-3631.
11. He TC, Sparks AB, Rago C, et al. Identification of c-MYC as a target of the APC pathway [J]. Science, 1998, 281 (5382): 1509-1512.
12. Shtutman M, Zhurinsky J, Simcha I, et al. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway [J]. Proc Natl Acad Sci U S A, 1999, 96 (10): 5522-5527.
13. Shimokawa T, Furukawa Y, Sakai M, et al. Involvement of the FGF18 gene in colorectal carcinogenesis, as a novel downstream target of the beta-catenin/T-cell factor complex [J]. Cancer Res, 2003, 63(19): 6116-6120.
14. Hung WC, Huang JS, Chuang LY. Antisense oligodeoxynucleotides targeted against different regions of cyclin D1 mRNA may exert different inhibitory effects on cell growth and gene expression [J]. Biochem Biophys Res Commun, 1996, 220 (3): 719-723.
15. Watson AJ. An overview of apoptosis and the prevention of colorectal cancer [J]. Crit Rev Oncol Hematol, 2006, 57 (2): 107-121.